Press Release: Medtronic receives FDA approval for attain Performa Quadripolar lead and Viva Quad CRT-Ds in United States

New system helps physicians deliver cardiac resynchronization therapy optimally and efficiently to heart failure patients.

Medtronic

News Well, Press Release, Regulatory/Clearance, Cardiac Rhythm Management, Food & Drug Administration (FDA), Minnesota, Pre-Market Approval (PMA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sqSUBb